MIG Capital AG β Full Portfolio
11 tracked investments Β· listed companies and verified rows first
BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions.
BiotechHealthtechMainz
Ozlem Tureci(Executive Officer)Ugur Sahin(Executive Officer)inSierk Poetting(Executive Officer)inSean Marett(Executive Officer)inRyan Richardson(Executive Officer)in
BoardChristoph Huber(Director)in
Board seatMichael MotschmannΒ· per SEC Form D
Co-investorsManta Ray VenturesOnsight VenturesPfizer Venture Investments
AMSilk produces biotech-derived silk protein yarns for textile applications including fashion, accessories, and automotive interiors, using fermentation-based bioprocessing instead of traditional sericulture.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsMunich, DE
Co-investorsNovo HoldingsAthos
Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator.
HardwareHealthtechMedical Devices
MIG portfolio company taken public.
Harpreet Singh(Founder)in
Co-investorsEMBL VenturesGrazia Equity GmbH
Innatera develops ultra-low-power neuromorphic processor chips that bring brain-like intelligence to the sensor edge, enabling everyday electronics and IoT devices to sense, understand, and respond in real time while keeping data on-device.
AI & Machine LearningHardwareIoTSemiconductors
Sumeet Kumar(Co-founder & Chief Executive Officer)inAmir Zjajo(Co-founder & Chief Scientific Officer)inRene van Leuken(Co-founder & Chief Advisory Officer)inUma Mahesh(Co-founder & Managing Director β India)Shreyas Derashri(Chief Commercial Officer)inMarc Bejas(Chief Financial Officer)in
Co-investorsMatterwave VenturesDelft Enterprises B.V.Invest-NL
iOmx Therapeutics is a biotech company developing novel cancer therapies.
AI & Machine LearningBiotechHealthtechMedical DevicesMunich, DE
Co-investorsM VenturesSofinnova Partners
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
BRAINNFONSiltectra
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.